Solara Active Pharma Sciences Limited

NSEI:SOLARA 株式レポート

時価総額:₹26.2b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Solara Active Pharma Sciences バランスシートの健全性

財務の健全性 基準チェック /16

Solara Active Pharma Sciencesの総株主資本は₹9.4B 、総負債は₹10.0Bで、負債比率は106.7%となります。総資産と総負債はそれぞれ₹23.5Bと₹14.1Bです。

主要情報

106.7%

負債資本比率

₹9.99b

負債

インタレスト・カバレッジ・レシオn/a
現金₹86.00m
エクイティ₹9.37b
負債合計₹14.14b
総資産₹23.51b

財務の健全性に関する最新情報

Recent updates

Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

Jun 05
Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

May 11
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Apr 19
Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Mar 13
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Feb 23
Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Jan 04
Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

May 12
Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Nov 08
Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Sep 30
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Aug 03
Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Jun 19
Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

Feb 17
Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Dec 21
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

With EPS Growth And More, Solara Active Pharma Sciences (NSE:SOLARA) Is Interesting

Oct 28
With EPS Growth And More, Solara Active Pharma Sciences (NSE:SOLARA) Is Interesting

財務状況分析

短期負債: SOLARAの 短期資産 ( ₹8.0B ) は 短期負債 ( ₹12.4B ) をカバーしていません。

長期負債: SOLARAの短期資産 ( ₹8.0B ) が 長期負債 ( ₹1.7B ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: SOLARAの 純負債対資本比率 ( 105.8% ) は 高い と見なされます。

負債の削減: SOLARAの負債対資本比率は、過去 5 年間で55.6%から106.7%に増加しました。

債務返済能力: SOLARAの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 10.9% )。

インタレストカバレッジ: SOLARAの負債に対する 利息支払いEBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。


貸借対照表


健全な企業の発掘